Search

everythinglearnresearchcommunity

for

Search:↓

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Low intensity ultrasound may reduce side effects of chemotherapy drugs like paclitaxel.

UTX is crucial for skin differentiation and health, especially in females.

Axolotls regenerate their spinal cord through a signal that recruits cells, influenced by cell sensitivity and signal spread.

Introducing the OTC gene improved symptoms in mice with OTC deficiency.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Botulinum toxin may help treat hair loss by relaxing scalp muscles, improving oxygen and blood flow.

The gene Tfap2b is essential for creating a type of stem cell in zebrafish that can become different pigment cells.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

A virus protein can activate a pathway that may lead to abnormal hair follicle development.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Botulinum toxin shows promise for treating skin conditions but needs more research for safety and effectiveness.

Thymus-derived Tregs, not peripherally-derived Tregs, primarily regulate type 1 diabetes in the NOD mouse model.

Applying a DNA vaccine to skin with active hair growth boosts immune response and protection against anthrax in mice.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

The TIP1 gene is crucial for normal plant cell growth in Arabidopsis.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Autoimmune reactions may cause both alopecia areata and HAM.

Botulinum toxin affects hair follicles, inhibiting TGF-B1 secretion; more research ongoing.